Safety and efficacy of anti-programmed cell death-1 monoclonal antibodies before and after allogeneic hematopoietic cell transplantation for relapsed or refractory Hodgkin lymphoma: a multicenter retrospective study
暂无分享，去创建一个
S. Fujiwara | R. Suzuki | K. Izutsu | K. Togitani | M. Onizuka | M. Nara | T. Kondo | M. Fukaya | I. Kawashima | T. Toubai | T. Teshima | J. Suzumiya | K. Matsuoka | T. Fukuda | R. Sakai | Sung-won Kim | Y. Inamoto | H. Nakazawa | Tomonari Takemura | M. Nakamae | Yuna Katsuoka | H. Iida | Takashi Tanaka | J. Sugita | N. Kawano | T. Kawakita | S. Tamura | S. Yoshioka | A. Ito | S. Terakura | A. Ishii | Yosuke Imai | K. Higuchi | Sung-Won Kim | Shin-ichiro Fujiwara | Satoshi Yoshioka